An Open-Label, Fixed-Sequence Study in Healthy Subjects to Assess the Effect of Ritonavir on the Single-Dose Pharmacokinetics of JNJ-61393215
Phase of Trial: Phase I
Latest Information Update: 20 Nov 2018
At a glance
- Drugs JNJ 61393215 (Primary) ; Ritonavir
- Indications Unspecified
- Focus Pharmacokinetics
- Sponsors Janssen Research & Development
- 08 Nov 2018 Status changed from active, no longer recruiting to completed.
- 31 Aug 2018 Status changed from not yet recruiting to active, no longer recruiting.
- 25 Jul 2018 New trial record